Community Health Systems Inc
NYSE: CYH · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-04-30
Community Health Systems Inc (CYH) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for CYH.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
CYH historical valuation range
Where current P/E sits in CYH's own 5Y range.
CYH intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
CYH valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 0.79x
P/S Ratio — History
Current: 0.03x
Is CYH overvalued in 2026?
Community Health Systems Inc (CYH) currently trades at $2.84 per share with a market capitalization of $395,976,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 45/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 0.8x, below its 5-year median of 1.5x. The PEG ratio of 2.38 indicates the price has run ahead of the underlying growth rate.
Looking at its own history, CYH is currently trading cheaper than 93% of the last 5Y on P/E. This places it in the 7th percentile of its historical range, a level that has historically coincided with attractive entry points.
A standard DCF model does not produce reliable output for CYH under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: CYH appears richly valued on our framework, with a Smart Value Score of 45/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is CYH overvalued in 2026?
Based on a Smart Value Score of 45/100, CYH appears overvalued. Current price exceeds what fundamentals currently justify.
What is CYH's fair value?
Standard DCF is unreliable for CYH due to its current profitability profile. Revenue-based approaches such as EV/Sales or historical P/S percentile are more informative for this stock.
What P/E ratio does CYH trade at?
CYH trades at a P/E of 0.8x on trailing twelve-month earnings, compared to its 5-year median of 1.5x.
Is CYH a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 45/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does CYH's valuation compare to its history?
On P/E, CYH currently sits in the 7th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is CYH's Smart Value Score?
CYH's Smart Value Score is 45/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.